Cencora | COR - Sales Revenues

Stock Price
363.03
Daily Change
-1.35 -0.37%
Monthly
2.12%
Yearly
44.84%
Q1 Forecast
349.89

Cencora reported $85.9B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Ambu A/S DKK 1.56B 90M Dec/2025
Amplifon EUR 563.3M 29.55M Sep/2025
Apollo Hospitals Enterprise Ltd INR 64.77B 1.73B Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Brookdale Senior Living USD 813.16M 34.92M Sep/2025
Cencora USD 85.9B 5.2B Sep/2025
Convatec Group USD 1.26B 80M Dec/2025
Diasorin EUR 280M 26M Sep/2025
Encompass Health USD 1.54B 60M Dec/2025
Enovis USD 548.9M 15.64M Sep/2025
GE HealthCare Technologies USD 5.14B 137M Sep/2025
Gulf Medical Proj AED 185.37M 5.32M Jun/2025
Hoya 244.7B 10.21B Dec/2025
Med Life RON 787.96M 8.36M Sep/2025
Oriola-kd EUR 463.3M 30.6M Sep/2025
Pediatrix Medical Group USD -101.34M 126.58M Dec/2024
Rede D'or Sao Luiz BRL 14.6B 480M Sep/2025
Siemens Healthineers EUR 5.4B 920M Dec/2025
Solventum Corp USD 2.1B 60M Sep/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
Supermax Corporation Bhd MYR 205.56M 50.82M Sep/2025
Veradigm USD 151.9M 1M Sep/2022
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025